1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Nelson Chao: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation MPH966, Placebo - Hematologic Malignancy | Phase 1 / Phase 2 | Withdrawn | Nelson Chao | 2021-09-01 | 2020-03-20 | |
| Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT CMV Specific T Cell donor lymphocyte infusion - Cytomegalovirus Infections | Phase 1 | Terminated | Nelson Chao | 5 | 2011-02-01 | 2017-06-05 |
Cytomegalovirus Infections (1) · Hematologic Neoplasms (1)
United States (2)
Anthony Sung, MD (1)